Skip to main navigation Skip to search Skip to main content

Bronchoscopic Lung Volume Reduction Coil Treatment for Severe Emphysema: A Systematic Review and Meta-Analysis of Individual Participant Data

  • Sharyn A. Roodenburg
  • , Jorine E. Hartman
  • , Gaëtan Desleé
  • , Felix J.F. Herth
  • , Karin Klooster
  • , Frank C. Sciurba
  • , Pallav L. Shah
  • , Arschang Valipour
  • , Zaid Zoumot
  • , Dirk Jan Slebos
  • University of Groningen
  • CHU de Reims
  • Heidelberg University 
  • University of Pittsburgh
  • Royal Brompton Hospital
  • Chelsea and Westminster Hospital
  • Imperial College London
  • Klinik Floridsdorf

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Background: Lung volume reduction coil (LVR-coil) treatment provides a minimally invasive treatment option for severe emphysema patients which has been studied in multiple clinical trials. Objectives: The aim of the study was to assess the effect of LVR-coil treatment on pulmonary function, quality of life, and exercise capacity using individual participant data. Method: PubMed, Web of Science, and EMBASE were searched until May 17, 2021. Prospective single-arm and randomized controlled trials that evaluated the effect of LVR-coil treatment on forced expiratory volume in 1 s (FEV1), residual volume (RV), St. George Respiratory Questionnaire (SGRQ) total score, and/or 6-min walk distance (6MWD) and were registered in an official clinical trial database were eligible for inclusion. Individual patient data were requested, and a linear mixed effects model was used to calculate overall treatment effects. Results: Eight trials were included in the final analysis, representing 680 individual patients. LVR-coil treatment resulted in a significant improvement in FEV1 at 3-(0.09 L [95% confidence interval (95% CI): 0.06-0.12]) and 6-month follow-up (0.07 L [95% CI: 0.03-0.10]), a significant reduction in RV at 3-(-0.45L [95% CI:-0.62 to-0.28]), 6-(-0.33L [95% CI:-0.52 to-0.14]), and 12-month follow-up (-0.36L [95% CI:-0.64 to-0.08]), a significant reduction in SGRQ total score at 3-(-12.3 points [95% CI:-15.8 to-8.8]), 6-(-10.1 points [95% CI:-12.8 to-7.3]), and 12-month follow-up (-9.8 points [95% CI:-15.0 to-4.7]) and a significant increase in 6MWD at 3-month follow-up (38 m [95% CI: 18-58]). Conclusions: LVR-coil treatment in emphysema patients results in sustained improvements in pulmonary function and quality of life and shorter lived improvements in exercise capacity. Since the owner of this LVR-coil has decided to stop the production and newer generations LVR-coils are currently being developed, these results can act as a reference for future studies and clinical guidance.

Original languageEnglish
Pages (from-to)697-705
Number of pages9
JournalRespiration
Volume101
Issue number7
DOIs
StatePublished - 1 Jul 2022

Keywords

  • Bronchoscopic lung volume reduction
  • Bronchoscopy
  • Chronic obstructive pulmonary disease
  • Emphysema
  • Meta-analysis

Fingerprint

Dive into the research topics of 'Bronchoscopic Lung Volume Reduction Coil Treatment for Severe Emphysema: A Systematic Review and Meta-Analysis of Individual Participant Data'. Together they form a unique fingerprint.

Cite this